Optimized radioiodine therapy of Graves' disease: Analysis of the delivered dose and of other possible factors affecting outcome

European Journal of Endocrinology

Volumn 141, Issue 2, 1999, Pages 117-121

  Catargi, Bogdan ^a,b   Leprat, Frédéric ^a   Guyot, Martine ^a   Valli, Nathalie ^a   Ducassou, Dominique ^a   Tabarin, Antoine ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LIOTHYRONINE; THYROID ANTIBODY; THYROID PEROXIDASE; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; DOSIMETRY; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE THERAPY;

ADULT; ANALYSIS OF VARIANCE; FEMALE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; THYROID GLAND; THYROID HORMONES; TREATMENT OUTCOME;

EID: 0032779489     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1410117     Document Type: Article

References (19)

1. Solomon B, Glinoer D, Lagasse R & Wartofsky L. Current trends in the management of Graves' disease. Journal of Clinical Endocrinology and Metabolism 1990 70 1518-1524.
2. Shapiro B. Optimization of radioiodine therapy of thyrotoxicosis: what have we learned after 50 years? Journal of Nuclear Medicine 1993 34 1638-1641.
3. Bockisch A, Jamitzky T, Derwanz R & Biersack HJ. Optimized dose planning of radioiodine therapy of benign thyroidal diseases. Journal of Nuclear Medicine 1993 34 1632-1638.
4. Franklyn JA, Daykin J, Drole Z, Farmer M & Sheppard MC. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clinical Endocrinology 1991 34 71-76.
5. Reiners C. Radioiodine therapy of Graves' disease: late results. In The Various Types of Hyperthyroidism. Eds D Reinwein & PC Scriba. Urban & Schwarzenberger, Merck Symposium 1988, Düsseldorf, Germany, 1987.
6. Chiovato L, Fiore E, Vitti R, Rocchi T, Rago D & Dokic F. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyroid-blocking antibodies and radioiodine-induced thyroid damage. Journal of Clinical Endocrinology and Metabolism 1997 83 40-46.
7. Tuttle RM & Patience T. Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 1995 5 243-247.
8. Hancock LD, Tuttle RM, LeMar H, Bauman J & Patience T. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clinical Endocrinology 1997 47 425-430.
9. Marinelli LD, Quimby EH & Hine GJ. Dosage determination with radioactive isotopes. American Journal of Roetgenology 1948 59 260-281.
10. 131I therapy of hyperthyroidism ablative? Thyroidology Clinical and Experimental 1992 4 103-106.
11. Jarlov AE, Hegedüs L, Kristensen LO, Nygaard B & Hansen JM. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while? Clinical Endocrinology 1995 43 325-329.
12. 131I therapy. Lancet 1976 2 73-75.
13. Hegedüs L & Faber J. Calculation of the ideal dose of radioiodine for treatment of thyroid disease. European Journal of Endocrinology 1995 132 544-545.
14. Aizawa Y, Yoshida K, Kaise N, Fukazawa H, Kiso Y & Sayama N. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis. Clinical Endocrinology 1997 46 1-5.
15. Lowdell CP, Sathis GS, Cosgrove DO, Dobbs HJ, McCready VR & Harmer CL. Low-dose in treatment of Graves' disease. Journal of the Royal Society of Medicine 1985 78 197-202.
16. Charkes ND. Graves' disease with functioning nodules (Marine-Lenhart syndrome). Journal of Nuclear Medicine 1972 13 885-892.
17. Fower MA, al Saadi A, Harmer CI, McCready VR & Ott RJ. Dose-response study on thyrotoxic patients undergoing PET and radioiodine therapy. European Journal of Nuclear Medicine 1994 6 21-25.
18. 131iodine activity. Results from a prospective, randomized, multicentre study. European Journal of Clinical Investigation 1995 25 186-193.
19. Blomfield GW, Jones JC, MacGregor AG, Miller H, Wayne EJ & Weetch RS. Treatment of thyrotoxicosis with radioactive iodine - review of 140 cases. British Medical Journal 1995 2 1223-1229.